Literature DB >> 20461527

Long-term regulation of Na,K-ATPase pump during T-cell proliferation.

Inna Karitskaya1, Nikolay Aksenov, Irina Vassilieva, Valerii Zenin, Irina Marakhova.   

Abstract

The aim of the study was to elucidate the mechanism responsible for the proliferation-related regulation of Na,K-ATPase pump. Our data demonstrate that in mitogen-stimulated human blood lymphocytes, enhanced ouabain-sensitive Rb(K) fluxes in the middle/late stage of G(0)/G(1)/S transit are associated with the increased number of Na,K-ATPase pumps expressed at the cell surface (as determined by the [(3)H]ouabain binding). Analysis of total RNA (reverse transcription-polymerase chain reaction) and protein (Western blotting) showed a threefold increase in the level of Na,K-ATPase alpha1-subunit and beta1-subunit mRNAs and significant increase in the Na,K-ATPase alpha1-subunit protein during the first day of mitogen-induced proliferation. The elevated K transport as well as the increased expression of Na,K-ATPase is closely associated with the IL-2-dependent stage of T-cell response. The pharmacological inhibition of IL-2-induced MEK/ERK or JAK/STAT cascades suppressed the IL-2-induced proliferation and reduced the functional and protein expressions of Na,K-ATPase. It is concluded that during the lymphocyte transition from resting stage to proliferation, (1) long-term activation of Na,K-ATPase pump is due to the enhanced expression of Na,K-ATPase protein and mRNA, and (2) the cytokine signaling via the IL-2 receptor is necessary for the cell cycle-associated upregulation of Na,K-ATPase.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20461527     DOI: 10.1007/s00424-010-0843-z

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  36 in total

Review 1.  The sodium pump. Its molecular properties and mechanics of ion transport.

Authors:  Georgios Scheiner-Bobis
Journal:  Eur J Biochem       Date:  2002-05

Review 2.  Ion transport, membrane potential, and cytoplasmic pH in lymphocytes: changes during activation.

Authors:  S Grinstein; S J Dixon
Journal:  Physiol Rev       Date:  1989-04       Impact factor: 37.312

Review 3.  Transcription factors of the NFAT family: regulation and function.

Authors:  A Rao; C Luo; P G Hogan
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

Review 4.  Lymphocyte activation in health and disease.

Authors:  M J Berridge
Journal:  Crit Rev Immunol       Date:  1997       Impact factor: 2.214

5.  Early and delayed changes in potassium transport during the initiation of cell proliferation in CHO culture.

Authors:  I I Marakhova; T A Vinogradova; E V Yefimova
Journal:  Gen Physiol Biophys       Date:  1989-06       Impact factor: 1.512

6.  JAK3, STAT, and MAPK signaling pathways as novel molecular targets for the tyrphostin AG-490 regulation of IL-2-mediated T cell response.

Authors:  L H Wang; R A Kirken; R A Erwin; C R Yu; W L Farrar
Journal:  J Immunol       Date:  1999-04-01       Impact factor: 5.422

7.  Interleukin-2-dependent regulation of Na/K pump in human lymphocytes.

Authors:  Irina Marakhova; Inna Karitskaya; Nikolay Aksenov; Valerii Zenin; Tatjana Vinogradova
Journal:  FEBS Lett       Date:  2005-04-20       Impact factor: 4.124

8.  Tissue-specific expression of Na,K-ATPase beta-subunit. Does beta 2 expression correlate with tumorigenesis?

Authors:  N S Akopyanz; N E Broude; E P Bekman; E O Marzen; E D Sverdlov
Journal:  FEBS Lett       Date:  1991-09-02       Impact factor: 4.124

Review 9.  Brefeldin A: insights into the control of membrane traffic and organelle structure.

Authors:  R D Klausner; J G Donaldson; J Lippincott-Schwartz
Journal:  J Cell Biol       Date:  1992-03       Impact factor: 10.539

10.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes.

Authors:  Jo Vandesompele; Katleen De Preter; Filip Pattyn; Bruce Poppe; Nadine Van Roy; Anne De Paepe; Frank Speleman
Journal:  Genome Biol       Date:  2002-06-18       Impact factor: 13.583

View more
  7 in total

1.  Carnosine prevents necrotic and apoptotic death of rat thymocytes via ouabain-sensitive Na/K-ATPase.

Authors:  Larisa V Smolyaninova; Alexander A Dergalev; Konstantin Y Kulebyakin; David O Carpenter; Alexander A Boldyrev
Journal:  Cell Biochem Funct       Date:  2012-07-04       Impact factor: 3.685

2.  Monovalent ions and stress-induced senescence in human mesenchymal endometrial stem/stromal cells.

Authors:  Alla Shatrova; Elena Burova; Natalja Pugovkina; Alisa Domnina; Nikolaj Nikolsky; Irina Marakhova
Journal:  Sci Rep       Date:  2022-07-01       Impact factor: 4.996

3.  Ouabain inhibition of Na/K-ATPase across the retina prevents signed refractive compensation to lens-induced defocus, but not default ocular growth in young chicks.

Authors:  Melanie J Murphy; Sheila Gillard Crewther
Journal:  F1000Res       Date:  2013-03-28

4.  Time-Dependent Regulation of IL-2R α-Chain (CD25) Expression by TCR Signal Strength and IL-2-Induced STAT5 Signaling in Activated Human Blood T Lymphocytes.

Authors:  Alla N Shatrova; Elena V Mityushova; Irina O Vassilieva; Nikolay D Aksenov; Valery V Zenin; Nikolay N Nikolsky; Irina I Marakhova
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

5.  Proliferation-related changes in K+ content in human mesenchymal stem cells.

Authors:  Irina Marakhova; Alisa Domnina; Alla Shatrova; Aleksandra Borodkina; Elena Burova; Natalja Pugovkina; Victoria Zemelko; Nikolay Nikolsky
Journal:  Sci Rep       Date:  2019-01-23       Impact factor: 4.379

6.  Intracellular K+ and water content in human blood lymphocytes during transition from quiescence to proliferation.

Authors:  Irina Marakhova; Valentina Yurinskaya; Nikolay Aksenov; Valeriy Zenin; Alla Shatrova; Alexey Vereninov
Journal:  Sci Rep       Date:  2019-11-07       Impact factor: 4.379

Review 7.  Transcriptional regulators of Na,K-ATPase subunits.

Authors:  Zhiqin Li; Sigrid A Langhans
Journal:  Front Cell Dev Biol       Date:  2015-10-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.